Peregrine Capital Management’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.48M Sell
430,185
-37,519
-8% -$419K 0.15% 223
2026
Q1
$5.57M Sell
467,704
-44,780
-9% -$458K 0.21% 147
2025
Q4
$5.1M Sell
512,484
-22,996
-4% -$220K 0.16% 194
2025
Q3
$4.79M Sell
535,480
-1,585
-0.3% -$14.7K 0.14% 221
2025
Q2
$5.06M Sell
537,065
-17,954
-3% -$158K 0.15% 204
2025
Q1
$6.02M Sell
555,019
-30,186
-5% -$304K 0.2% 155
2024
Q4
$5.57M Sell
585,205
-21,182
-3% -$214K 0.16% 203
2024
Q3
$6.81M Buy
606,387
+64,959
+12% +$690K 0.21% 145
2024
Q2
$5.41M Sell
541,428
-1,867
-0.3% -$19K 0.16% 219
2024
Q1
$6.25M Buy
+543,295
New +$4.61M 0.18% 198

Other funds holding AHCO

Peregrine Capital Management's AHCO Position: Q2 2026 in Review

Peregrine Capital Management reduced its AdaptHealth (AHCO) stake by 8% in Q2 2026, selling an estimated $419K and leaving 430,185 shares worth $4.48M. The position accounts for 0.15% of the portfolio, ranked #223.

Peregrine Capital Management first reported a position in AHCO in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.81M in Q3 2024. 35 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Peregrine Capital Management held 430,185 shares of AdaptHealth worth $4.48M as of Q2 2026.
  • Peregrine Capital Management sold 37,519 AdaptHealth shares in Q2 2026, an estimated $419K.
  • AdaptHealth made up 0.15% of Peregrine Capital Management's portfolio in Q2 2026, its #223 holding.
  • Peregrine Capital Management first reported a position in AdaptHealth in Q1 2024 and has held it in 10 quarters since.
  • Peregrine Capital Management's AdaptHealth position peaked at $6.81M in Q3 2024.
  • 35 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Peregrine Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.